[Infantile haemangioma; refer and treat on time]
SourceNederlands Tijdschrift voor Geneeskunde, 163, (2019), article D3700
Article / Letter to editor
Display more detailsDisplay less details
Nederlands Tijdschrift voor Geneeskunde
SubjectRadboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Infantile haemangioma is a relatively common and usually benign condition that occurs in infancy. Nonetheless, during the growth phase in the first weeks or months of the child's life it can have a profound impact on both the patient and parents, especially when functional problems or complications occur. Care and attention by physicians is important at this stage; the information given by many healthcare practitioners that the infantile haemangioma will spontaneously disappear is often insufficiently reassuring and is not always correct. With the discovery of the therapeutic potential of oral beta-blockers, ten years ago, treatment has become more effective and more straightforward. Counselling on treatment with beta-blockers should be considered with low threshold. Consultation of a centre of expertise, possibly electronically, can facilitate timely referral so that growth of the infantile haemangioma can be stopped and complications may be prevented. Managing anxiety levels among parents/carers can be an important reason for consultation of a centre of expertise. During the growth phase of infantile haemangioma, careful monitoring is indicated, since time is of the essence for cases of infantile haemangioma with impending complications, associations or severe deformation.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.